Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
ΔCS-PP
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/02/2021
ΔABP-α2
Potential treatment - theoretical effect Experimental Antiviral Mar/01/2021
Δ9-Tetrahydrocannabinol
Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Dec/05/2020
 6-Thioguanine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/02/2020
[SARSHRC-PEG4]2-chol
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/17/2021
[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyfuran-2-yl](sodiylium)methyl [({[5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyfuran-2-yl]methoxy}(sodiooxo)phosphoryl)oxy]phosphonate
Potential treatment - theoretical effect Experimental Antiviral Dec/19/2020
[3-(5-methoxy-2-hydroxy benzylidene amino)-2(5-methoxy-2-hydroxyphenyl)-2,3-dihydro quinazoline-4(1H)-one]
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021
[2-[[(3R)-1,1-Dioxothiolan-3-yl]-(2-methylpropyl)amino]-2-oxoethyl] 3-(furan-2-carbonylamino)-4-methylbenzoate
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
[2-[[(2R)-Butan-2-yl]-[(3R)-1,1-dioxothiolan-3-yl]amino]-2-oxoethyl] 3-(furan-2-carbonylamino)-4-methylbenzoate
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate
Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020
[(3E)-3-[(3,4-Dihydroxyphenyl)methylidene]-2-hydroxycyclohexen-1-yl]-phenylmethanone
Potential treatment - theoretical effect Natural product Antiviral Jan/05/2021
[(2S,4R)-4-Hydroxy-2-methoxy-5-[(2S)-6-oxo-2,3-dihydropyran-2-yl]pentyl] 5-oxo-5-[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]pentanoate
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
[(2S,3S,4S,5S)-5-Hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate
Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020
[((5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE)]
Potential treatment - theoretical effect Experimental Antiviral Sep/02/2020
ZyCoV-D
Emergency use authorization Experimental Vaccine Mar/26/2020
Zotatifin
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Zotarolimus
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/23/2020
Zofin
Potential treatment - clinical evidence Experimental Other treatment Mar/17/2021
ZINC96222891
Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020
ZINC95559591
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020